Tech Company Financing Transactions
Citius Pharmaceuticals Funding Round
On 3/7/2024, Citius Pharmaceuticals received $2.4 million in investment from New Jersey Economic Development Authority.
Transaction Overview
Company Name
Announced On
3/7/2024
Transaction Type
Venture Equity
Amount
$2,400,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11 Commerce Dr. 1st Floor
Cranford, NJ 07016
USA
Cranford, NJ 07016
USA
Phone
Website
Email Address
Overview
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, oncology, stem cell therapy and unique prescription products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Myron Holubiak
Chief Executive Officer
Leonard Mazur
Chief Financial Officer
Jaime Bartushak
Chief Medical Officer
Myron Czuczman
Vice President
Ilanit Allen
Vice President
John Westman
VP - Bus. Development
Paul Sowyrda
VP - Bus. Development
Jay Wadekar
VP - Manufacturing
Kelly Creighton
VP - Operations
Gary Talarico
VP - Regulatory Affairs
Alan Lader
Browse more venture capital transactions:
Prev: 3/7/2024: Pro Shop venture capital transaction
Next: 3/7/2024: DevEngine venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs